Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (5): 777-781    DOI: 10.12891/ceog3595.2017
Original Research Previous articles | Next articles
Does increase in body mass index effect primary dysmenorrhea?
M. Temur1, 3, *(), U. Gök Balci2, Y. A. Güçlü2, B. Korkmaz3, P.Ö. Özbay4, N. Soysal2, Ö. Yilmaz1, T.T. Yilmazer2, T. Çift3, K. Öngel2
1 Department of Obstetrics and Gynecology, Manisa Merkezefendi State Hospital, Manisa, Turkey
2 Department of Family Medicine, Tepecik Research and Training Hospital, İzmir, Turkey
3 Department of Obstetrics and Gynecology, Bursa Yüksek İhtisas Research and Training Hospital, Bursa, Turkey
4 Department of Obstetrics and Gynecology, Aydın Obstetrics and Pediatrics Hospital, Aydın, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: In the present study, the aim was to evaluate the relationship between obesity and dysmenorrhea and the effects of sociodemographic features on it. Materials and Methods: A total of 303 women were included in the study .Grading of severity of dysmenorrhea was made based on Verbal Multidimensional Scoring System (VMSS). Results: When correlations between severity of dysmenorrheic symptoms and patients were assessed, there was a statistically significant difference between the rates of chronic disease in the dysmenorrhea groups and the rates of dysmenorrhea history in the family (p = 0.037 and p = 0.008, respectively). There was a statistically significant difference in the mean body mass index (BMI) in the dysmenorrhea grades (p < 0.001). The mean BMI for those without dysmenorrhea was higher than those with mild or moderate dysmenorrhea. Those with severe dysmenorrhoea had a significantly higher mean BMI than those with mild dysmenorrhea (p <0.001, p = 0.002, and p = 0.009, respectively). There was a statistically significant difference in dysmenorrheal grades and BMI groups (p = 0.002). The severity of dysmenorrhoea in those with a BMI of 30 and above was greater than those of mild and moderate ones. Conclusion: The main underlying cause of dysmenorrhea may not be obesity, but it may be one of the correctible predisposing factors. Balanced diet and trying to decrease one's BMI within normal limits may lower the incidence of dysmenorrhea.
Key words:  Dysmenorrhea      Obesity      Body mass index     
Published:  10 October 2017     
*Corresponding Author(s):  M. TEMUR     E-mail:  drmuzaffer@yahoo.com

Cite this article: 

M. Temur, U. Gök Balci, Y. A. Güçlü, B. Korkmaz, P.Ö. Özbay, N. Soysal, Ö. Yilmaz, T.T. Yilmazer, T. Çift, K. Öngel. Does increase in body mass index effect primary dysmenorrhea?. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 777-781.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3595.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I5/777

[1] Amanda M. Wang, Alan J. Lee, Shannon M. Clark. The effects of overweight and obesity on pregnancy-related morbidity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 999-1009.
[2] Alexandra Berezowsky, Howard Berger. Gestational weight gain and long-term postpartum weight retention[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 466-471.
[3] Ovadya Rosenbluh, Asnat Walfisch. Birth defects associated with obesity[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 472-477.
[4] Eun Jeong Choi, Jung Yeol Han. Pregnancy outcomes after inadvertent exposure of anti-obesity drugs during pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 514-522.
[5] Gideon Koren, Yusuf C Kaplan. Obesity, neural tube defects and folic acid—A complex relationship[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 223-227.
[6] S. Yamamura, K. Yamaguchi, I. Hayashi, N. Nagai, N. Sakane, A. Ikeda, M. Takakura, I. Emoto, M. Ujita, K. Kawasaki, K. Abiko, Y. Takao, K. Takakura, I. Konishi. Postpartum hemorrhage is associated with neonatal body weight, pre-pregnancy body mass index, and maternal weight gain[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 920-925.
[7] J.H. Check, D. Check, R. Cohen. A novel effective treatment for menière’s disease – dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 807-809.
[8] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[9] K.Y. Yun, S.Y. Hwang, H.J. Lee, S.C. Kim, J.K. Joo, D.S. Suh, K.H. Kim, K.S. Lee. The association of body mass index with incidence, stage and recurrence of endometriosis: case-control study in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 53-56.
[10] F. Fabbian, A. Coppola, R. Cappadona, A. De Giorgi, S. Fanaro, E. Di Simone, R. Manfredini, P. Greco, M. A. Rodríguez Borrego, P. J. López Soto. Ambulatory blood pressure monitoring during pregnancy: an Italian experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 89-92.
[11] L. Yuanmei, Z. Qian, X. Fengsen, W. Yankui. Restricted gestational weight gain in overweight/obese women with gestational diabetes mellitus and pregnancy outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 763-769.
[12] M. Trisovic, O. Mladenovic, J. Bila, K. Lalić, D. Kisic Tepavcevic. The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 776-778.
[13] M. Mizgier, G. Jarząbek-Bielecka, K. Mruczyk, W. Kędzia. The role of obesity and environmental factors such as diet and physical activity in the etiopathogenesis of fertility disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 516-520.
[14] H. Kwon, J.E. Shin, H. Kim. A novel treatment of severe dysmenorrhea due to adenomyosis: a case series of 3 infertile patients treated with dopamine agonist and in vitro fertilization-embryo transfer resulting in successful pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 637-640.
[15] Z. Kalem, M.N. Kalem, N. Akgün, A.E. Kaya, B. Bakirarar, S. Aydın. The relationship between the levels of anti-Müllerian hormone, vaspin, visfatin, and the patterns of nutrition and menstruation in non-polycystic ovary syndrome and non-obese young women[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 258-264.
No Suggested Reading articles found!